Molecure SA (MOCP)

Warsaw
Currency in PLN
9.10
+0.14(+1.56%)
Closed
MOCP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
8.959.10
52 wk Range
8.3120.35
Key Statistics
Edit
Bid/Ask
9.08 / 9.10
Prev. Close
8.96
Open
8.98
Day's Range
8.95-9.1
52 wk Range
8.31-20.35
Volume
41.45K
Average Volume (3m)
29.05K
1-Year Change
-55.2%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MOCP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
18.25
Upside
+100.55%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Molecure SA Company Profile

Molecure S.A., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland. The company is involved in the development of OATD-01, a chitotriosidase/AMCASE inhibitor that has completed phase I clinical trial for the treatment of sarcoidosis, as well as in preclinical stage to treat idiopathic pulmonary fibrosis and NASH. It also develops OATD-02, an arginase 1 and arginase 2, which is in Phase I clinical trial for the treatment of cancer; USP7, USP21, and YKL-40 for the treatment of cancer; and Deubiquitinase program. The company was formerly known as OncoArendi Therapeutics S.A. and changed its name to Molecure S.A. in March 2022. Molecure S.A. was founded in 2012 and is headquartered in Warsaw, Poland.

Employees
105
Market
Poland

Compare MOCP to Peers and Sector

Metrics to compare
MOCP
Peers
Sector
Relationship
P/E Ratio
−4.9x−2.8x−0.6x
PEG Ratio
−0.140.000.00
Price/Book
1.9x2.3x2.6x
Price / LTM Sales
99.2x8.4x3.1x
Upside (Analyst Target)
103.7%125.6%48.8%
Fair Value Upside
Unlock6.6%7.5%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 18.25
(+100.55% Upside)

Earnings

Latest Release
Oct 31, 2024
EPS / Forecast
-- / --
Revenue / Forecast
600.00K / 600.00K
EPS Revisions
Last 90 days

FAQ

What Is the Molecure (MOCP) Stock Price Today?

The Molecure stock price today is 9.10

What Stock Exchange Does Molecure Trade On?

Molecure is listed and trades on the Warsaw stock exchange.

What Is the Stock Symbol for Molecure?

The stock symbol for Molecure is "MOCP."

What Is the Molecure Market Cap?

As of today, Molecure market cap is 153.21M.

What is Molecure Earnings Per Share?

The Molecure EPS is -1.83.

What Is the Next Molecure Earnings Date?

Molecure will release its next earnings report on 20 Mar 2025.

From a Technical Analysis Perspective, Is MOCP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.